(S)-α-Methylbenzyl Ricinoleamide – 1 mg

Brand:
Cayman
CAS:
1246776-22-6
Storage:
-20
UN-No:
De Minimis - 1170 / 3

(S)-α-Methylbenzyl ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzylamine.{28387} It demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI50 value of 6.9 µM.{28387}  

 

Available on backorder

SKU: - Category:

Description

A fatty acid amide derived from ricinoleic acid and methyl benzylamine that demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI50 value of 6.9 µM


Formal name: 12R-hydroxy-N-[(1S)-1-phenylethyl]-9Z-octadecenamide

Synonyms: 

Molecular weight: 401.6

CAS: 1246776-22-6

Purity: ≥98%

Formulation: A solution in ethanol


Product Type|Biochemicals|Lipids|Fatty Amides||Product Type|Biochemicals|Lipids|Octadecanoids||Research Area|Cancer